Pharmaceutical companies as well as their partners are feeling the heat. They are facing unprecedented challenges on a global scale. More so than ever, their business strategies are being put to the test. How well they do will depend on the resilience of their operations and the vision of their leaders.
It’s hard to believe that another year has passed, but like the sands through the hourglass these are the days of our pharma lives. Once again, we are delighted to provide you with our Year in Preview issue. While this time of year is often used for reflection, we like to take a moment to consider what the future may hold, which is why this is a preview and not a review. While it is important to know how we got here, we believe it’s more important to lay the groundwork to get to the next plateau.
In the days ahead, the country will learn what President-elect Barack Obama’s plans are to address the healthcare crisis in the country. Some hypothesize that there will be a move toward price controls and universal healthcare, while other pundits believe there could be a more moderate platform in the works. PhRMA, as well as other industry organizations, will be watching closely and has offered its assistance to help address the difficult…